Vivo Ventures VII Affiliates Fund, L.P. is 10% Owner at Aclaris Therapeutics, Inc. (ACRS). They have made 5 open-market trades across 4 companies since 2013, most recently 2017-09-14.
CIK 0001538309
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3.7M since 2015, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CDXS | SELL | 2017-09-14 | 2017-09-18 | $5.78 | $12.3M | +12.8% | +24.8% | +34.2% |
| ACRS | SELL | 2017-02-28 | 2017-03-02 | $30.92 | $20.1M | -0.8% | -1.9% | -22.6% |
| DNAI | BUY | 2015-07-21 | 2015-07-21 | $17.00 | $3.7M | -27.9% | -8.5% | -8.5% |
| MEIP | SELL | 2013-10-25 | 2013-10-29 | $8.21 | $2.5M | -14.3% | +3.7% | +3.7% |
| MEIP | SELL | 2013-06-11 | 2013-06-13 | $7.80 | $1.8M | -14.3% | +3.7% | +3.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.